Quick links

Secure login

Secure file transfer protocol

Register or renew user

Contact us

Trouble logging in? Forgot password? We can help!

philavax@phila.gov

215-685-6784

215-238-6944

Register a clinic

Fill out both forms, then either email or fax them to us at the contact above.

Clinic registration form
Enity confidentiality form

On behalf of patients

Patient update request

Looking for something else?

PhilaVax program info
Flat file reporting guide
More PhilaVax resources

VFAAR

2020 Enrollment Opens Today! The Philadelphia Immunization Program’s Vaccines for Child (VFC) & Vaccines for Adults at Risk (VFAAR) enrollment opens today! Log into PhilaVax and begin your enrollment right now! Annual enrollment is required to receive federally funded vaccines regardless of if it's your first...

03 February, 2020

2020 Enrollment begins February 3rd Happy new year! The Philadelphia Immunization Program annual Vaccines for Children (VFC) and Vaccines for Adults at Risk (VFAAR) enrollment opens on Monday, February 3rd. Start the new year off on the right foot. Complete your VFC/VFAAR enrollment on time. This year’s enrollment...

14 January, 2020

VFC/VFAAR Re-enrollment is right around the corner! The Philadelphia VFC/VFAAR annual re-enrollment period is November 1-30, 2018. Re-enrollment is a requirement for the VFC/VFAAR programs. Failure to complete the re-enrollment form will result in un-enrollment from the program. We’re very excited to announce that for the first...

23 October, 2018

Protect adults from shingles with the new Shingrix vaccine Shingrix (recombinant zoster vaccine) is a vaccine to protect healthy adults age 50 and older from shingles. You can now order Shingrix through the Vaccines for Adults At Risk program (VFAAR) for adults 50+ and uninsured. About Shingrix Administer...

09 June, 2018

Recommendations for the Meningococcal Serogroup B Vaccine The Philadelphia Department of Public Health is issuing recommendations on when healthcare providers should recommend and administer the meningococcal serogroup B (MenB) vaccine to patients. In October 2014 and January 2015, the FDA licensed two MenB vaccines for people...

14 October, 2017

The Philadelphia Department of Public Health is issuing recommendations on when healthcare providers should recommend and administer the meningococcal serogroup B (MenB) vaccine to patients. In October 2014 and January 2015, the FDA licensed two MenB vaccines for people age 10 to 25 years. Guidelines on...

14 October, 2017